PL
EN
What we do
At Polpharma Biologics we are focused on developing the next generation of biosimilars to improve patient access and reduce health care costs.
Our pipeline is continuously growing and our late stage products are nearing the market. We look to partner with some of the worlds largest biotech so our biosimilars can reach those that need them.
6+
biologics in the pipeline
3
sites
>10000l
Bioreactor capacity
1300
People employed
Over 50
Polish scientists returned from abroad
We care
our driving value for what we do
Our cell line development, process development and analytical development team set the foundation for all our programs. They are the first step in creating our pipeline.
Learn moreWe have state of the art manufacturing facilities for both mammalian and microbial manufacturing for clinical for preclinical, clinical and commercial supply, including fill and finish.
Learn moreOur clinical operations group manages pre-clinical and clinical trials, a lengthy process but critical to ensuring our biosimilars are safe and effective for the patients that need them most.
Learn more
Polpharma Biologics, an international biotech company dedicated to the development and manufacturing of biosimilars,...
Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars, an...